FDA OKs Trial For Gene-Edited Pig Kidney Transplants
Stat reports that Boston-based eGenesis will likely begin the study early next year, aimed at helping patients with end-stage kidney disease. Other pharma and tech news is on Novartis, Summit Therapeutics, "smart cartilage," and more.